Eli Lilly and Company’s (LLY) Foundayo and Zepbound Set To Be Covered for Millions of Americans

Eli Lilly and Company (NYSE:LLY) is one of the best stocks to buy now for long term growth. Eli Lilly and Company (NYSE:LLY) announced on May 28 that its full obesity medicine portfolio would now be covered by all three of the largest pharmacy benefit managers in the nation. This considerably expands the number of Americans who can use their existing insurance to access FDA-approved options.

Eli Lilly Expands Vaccine Push with Three Acquisitions, Reuters Reports

Management reported that coverage from CVS Caremark Commercial Template would begin from June 1 for Foundayo, and coverage would continue uninterrupted for current Zepbound patients, with access broadening across template plans by October 1. In addition, eligible patients with commercial coverage can access both medicines for as little as $25 a month. Eli Lilly and Company (NYSE:LLY) also stated that Medicare Part D beneficiaries may also be eligible to pay $50 per month for their obesity medicines beginning July 1 through the Medicare GLP-1 Bridge program.

For reference, Reuters reported on April 24 that according to analysts citing IQVIA data, Eli Lilly and Company’s (NYSE:LLY) Foundayo was prescribed 3,707 times in the United States in the second week following its launch earlier in the month. The pill had 1,390 prescriptions in its first week of launch.

Eli Lilly and Company (NYSE:LLY) develops, manufactures, discovers, and sells pharmaceutical products. These products span oncology, diabetes, immunology, neuroscience, and other therapies.

While we acknowledge the risk and potential of LLY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than LLY and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1